GlycoDisplay Aps

GlycoDisplay develops novel biopharmaceuticals by modifying sugars. The proprietary technology applies targeted cell engineering to display different glycans on cells and proteins. GlycoDisplay is a spin-out from University of Copenhagen, Center for Glycomics, which is world leading within the field of glyco-engineering and glycomics.

Address
Blegdamsvej 3
DK-2200 - København N
Denmark

Website: http://glycodisplay.com/

Contact

Name: Claus Kristensen
Position: professor, CEO
Email: clausk@sund.ku.dk